» Articles » PMID: 33077239

Rate of True Recurrent Implantation Failure is Low: Results of Three Successive Frozen Euploid Single Embryo Transfers

Overview
Journal Fertil Steril
Date 2020 Oct 20
PMID 33077239
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the true prevalence of recurrent implantation failure.

Design: Retrospective cohort study.

Setting: A private assisted reproductive technology center.

Patient(s): Women (n = 4,429) with anatomically normal uterus who underwent up to three consecutive frozen euploid single embryo transfers (FE-SETs) were included in the study. Cycles with donor eggs or gestational carriers were excluded.

Intervention(s): None.

Main Outcome Measure(s): Cumulative outcomes from these cycles were analyzed. A logistic regression model was used to assess the differences of outcomes between first, second, and third FE-SET and a Kaplan-Meier curve as used to analyze cumulative implantation rate.

Result(s): The mean age of the patients included in the study was of 35.4 years. The sustained implantation rates of the first, second, and third FE-SET were 69.9%, 59.8%, and 60.3% per transfer, respectively. The cumulative sustained implantation rate after up to three consecutive FE-SET was 95.2%. The live birth rates after the first, second, and third FE-SET were 64.8%, 54.4%, and 54.1% per transfer, respectively. The cumulative live birth rate after up to three consecutive FE-SET was 92.6%. The miscarriage rate after observing a positive heartbeat was not different between the first (7.2%), second (8.8%), and third (12.7%) FE-SET.

Conclusion(s): Our findings suggest that true recurrent implantation failure is rare. For those patients with the ability to make euploid blastocysts, <5% would fail to achieve a clinical pregnancy with three embryos transferred. It remains to be further investigated whether this threshold identifies a truly recalcitrant group or simply a statistical certainty based on random variation.

Citing Articles

Comparative efficacy of intrauterine infusion treatments for recurrent implantation failure: a network meta-analysis of randomized controlled trials.

Jiang L, Wen L, Lv X, Tang N, Yuan Y J Assist Reprod Genet. 2025; .

PMID: 40035946 DOI: 10.1007/s10815-025-03436-2.


Transcriptomic landscape of cumulus cells from patients <38 years old with a history of poor ovarian response (POR) treated with platelet-rich plasma (PRP).

Roberts L, Herlihy N, Reig A, Titus S, Garcia-Milian R, Knight J Aging (Albany NY). 2025; 17(2):431-447.

PMID: 39976580 PMC: 11892918. DOI: 10.18632/aging.206202.


Embryo versus endometrial receptivity: untangling a complex debate.

Mercan R, Guzel Y, Usta I, Alper E Front Endocrinol (Lausanne). 2025; 16:1537847.

PMID: 39911920 PMC: 11797072. DOI: 10.3389/fendo.2025.1537847.


Utilizing MV-FLOW™ and multidimensional ultrasound characteristics for prognosticating FET outcomes in RIF patients: Study Protocol for a cross-sectional study.

Zhou Y, Liu L, Yang H, Lai Y, Gan D, Yang J PLoS One. 2025; 20(2):e0316028.

PMID: 39899518 PMC: 11790133. DOI: 10.1371/journal.pone.0316028.


Factors influencing endometrial receptivity in women with recurrent implantation failure.

Opuchlik K, Pankiewicz K, Pierzynski P, Sierdzinski J, Aleksejeva E, Salumets A BMC Womens Health. 2025; 25(1):15.

PMID: 39789542 PMC: 11715555. DOI: 10.1186/s12905-024-03531-z.